- 5.5Impact Factor
- 10.0CiteScore
- 15 daysTime to First Decision
Mesoporous Materials for Drug Delivery and Theranostics
This special issue belongs to the section “Drug Delivery and Controlled Release“.
Special Issue Information
Dear Colleagues,
Mesoporous materials, especially those made of silica, are capturing great interest thanks to their exceptional pore size and surface area and ease surface functionalization, thus enabling a broad series of intervention in the field of nanomedicine. For many years, these aspects have fostered a deep investigation of mesoporous nanoparticles to design and fabricate biocompatible, smart, and even mechanizable nanotools for controlled, stimuli-responsive drug or gene delivery up to the most recent theranostics applications, in particular for cancer therapy.
This Special Issue of Pharmaceutics is dedicated to the most recent advances in the use of mesoporous micro- and nanostructures for designing novel “smart” biomedical systems applied to drug delivery and theranostics. Participation with research papers, short communications, and reviews focused on these topics and describing the synthesis and characterization of mesoporous materials, also in a core–shell configuration with other nanomaterials and their functionalization with smart and stimuli-responsive gatekeepers, as well as reporter molecules or particles for diagnostic applications and their final in vitro and in vivo applications in the nanomedicine field, is highly encouraged.
Prof. Valentina Cauda
Dr. Giancarlo Canavese
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- high porosity
- colloidal dispersion
- host–guest interaction
- core–shell structures
- surface functionalization
- pore gatekeepers
- stimuli-responsive drug delivery
- cell targeting
- gene therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

